Safety of an Escherichia coli-expressed bivalent human papillomavirus (types 16 and 18) L1 virus-like particle vaccine: An open-label phase I clinical trial

An Escherichia coli-expressed recombinant bivalent human papillomavirus (types 16 and 18) vaccine candidate has been shown to be safe and immunogenic in preclinical trials. The safety of this vaccine was analyzed in an open-label phase I clinical trial in Jiangsu province, China. Thirty-eight health...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hu, Yuemei, Huang, Shou-Jie, Chu, Kai, Wu, Ting, Wang, Zhong-Ze, Yang, Chang-Lin, Cai, Jia-Ping, Jiang, Han-Min, Wang, Yi-Jun, Guo, Meng, Liu, Xiao-Hui, Huang, Hong-Jiang, Zhu, Feng-Cai, Zhang, Jun, Xia, Ning-Shao
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2014
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4185883/
https://ncbi.nlm.nih.gov/pubmed/24161937
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/hv.26846
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados